Chase Investment Counsel Corp. »

United Therapeutics Corporation shares owned by Chase Investment Counsel Corp.

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Chase Investment Counsel Corp. from 13F filings

Historical chart of Chase Investment Counsel Corp. investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Chase Investment Counsel Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Chase Investment Counsel Corp.

Quarter filed Position value Share count Share price at filing
2024-09-30 $492k 1.4k 357.82

More positions owned by Chase Investment Counsel Corp.

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Metropcs Communications (TMUS)
Arista Networks (ANET)
eBay (EBAY)
Alphabet Cap Stk Cl A (GOOGL)
Houlihan Lokey Cl A (HLI)
Vertiv Holdings Com Cl A (VRT)
Nortonlifelock (GEN)
Bank of New York Mellon Corporation (BK)
Goldman Sachs (GS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Chase Investment Counsel Corp.

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation